サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386608

アレルギー診断・治療の世界市場：動向、予測、競合分析（～2030年）

Allergy Diagnostics and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

アレルギー診断・治療の世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

アレルギー診断・治療の動向と予測

世界のアレルギー診断・治療の市場規模は、2024～2030年にかけてCAGR 6.5%で成長し、2030年までに約554億米ドルに達すると予測されています。この市場の主な促進要因は、小児および高齢者人口におけるアレルギー疾患の増加、IDV技術の採用拡大、診断ツールの改善です。世界のアレルギー診断・治療市場の将来は、食品、吸入、薬剤市場にビジネスチャンスがあり、有望視されています。

アレルギー診断・治療市場の洞察

Lucintelの予測では、診断検査に不可欠な消耗品の採用が増加しているため、予測期間中に消耗品が最も高い成長を遂げる見込みです。

この市場の中では、薬物アレルギーが、治療へのアクセスの増加や患者の薬物アレルギーに対する意識の高まりにより、最も高い成長が見込まれています。

北米は、アレルギーの発生件数が増加していることと、同地域における政府の取り組みが良好であることから、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問について回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがあるか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えるか？

目次

第1章 エグゼクティブサマリー

第2章 世界のアレルギー診断・治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のアレルギー診断・治療市場の動向（2018～2023年）および予測（2024～2030年）
  • 世界のアレルギー診断・治療市場：製品タイプ別
    • 機器
    • 消耗品
    • サービス
  • 世界のアレルギー診断・治療市場：アレルゲンタイプ別
    • 食品
    • 吸入
    • 薬剤
  • 世界のアレルギー診断・治療市場：検査タイプ別
    • In vivo Test
    • In vitro Test
  • 世界のアレルギー診断・治療市場：薬剤クラス別
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界のアレルギー診断・治療市場：地域別
  • 北米のアレルギー診断・治療市場
  • 欧州のアレルギー診断・治療市場
  • アジア太平洋のアレルギー診断・治療市場
  • その他の地域のアレルギー診断・治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界のアレルギー診断・治療市場の成長機会
    • アレルゲンタイプ別の世界のアレルギー診断・治療市場の成長機会
    • 検査タイプ別の世界のアレルギー診断・治療市場の成長機会
    • 薬剤クラス別の世界のアレルギー診断・治療市場の成長機会
    • 地域別の世界のアレルギー診断・治療市場の成長機会
  • 世界のアレルギー診断・治療市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のアレルギー診断・治療市場の生産能力拡大
    • 世界のアレルギー診断・治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • R-Biopharm
  • EUROIMMUN Medizinische Labordiagnostika
  • DASIT
  • AESKU
  • BioMerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics
目次

Allergy Diagnostics and Therapeutics Trends and Forecast

The future of the global allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets. The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

A more than 150-page report is developed to help in your business decisions.

Allergy Diagnostics and Therapeutics by Segment

The study includes a forecast for the global allergy diagnostics and therapeutics by product type, allergen type, test type, drug class, and region.

Allergy Diagnostics and Therapeutics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Allergy Diagnostics and Therapeutics Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug

Allergy Diagnostics and Therapeutics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • In Vivo Test
  • In Vitro Test

Allergy Diagnostics and Therapeutics Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-Cholinergic
  • Immuno-Modulators
  • Epinephrine
  • Immunotherapy

Allergy Diagnostics and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Allergy Diagnostics and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies allergy diagnostics and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the allergy diagnostics and therapeutics companies profiled in this report include-

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics

Allergy Diagnostics and Therapeutics Market Insights

Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Within this market, drug allergies is expected to witness highest growth due to increasing access to treatment and rising awareness of drug allergies among patients.

North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Features of the Global Allergy Diagnostics and Therapeutics Market

Market Size Estimates: Allergy diagnostics and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Allergy diagnostics and therapeutics market size by various segments, such as by product type, allergen type, test type, drug class, and region in terms of value ($B).

Regional Analysis: Allergy diagnostics and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, allergen types, test types, drug classes, and regions for the allergy diagnostics and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the allergy diagnostics and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the allergy diagnostics and therapeutics market size?

Answer: The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030.

Q.2 What is the growth forecast for allergy diagnostics and therapeutics market?

Answer: The global allergy diagnostics and therapeutics market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the allergy diagnostics and therapeutics market?

Answer: The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

Q4. What are the major segments for allergy diagnostics and therapeutics market?

Answer: The future of the allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key allergy diagnostics and therapeutics market companies?

Answer: Some of the key allergy diagnostics and therapeutics companies are as follows:

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics

Q6. Which allergy diagnostics and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Q7. In allergy diagnostics and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the allergy diagnostics and therapeutics market by product type (instruments, consumables, and services), allergen type (food, inhaled, and drug), test type (in vivo test and in vitro test), drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic, immuno-modulators, epinephrine, and immunotherapy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Allergy Diagnostics and Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Allergy Diagnostics and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Allergy Diagnostics and Therapeutics Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Services
  • 3.4: Global Allergy Diagnostics and Therapeutics Market by Allergen Type
    • 3.4.1: Food
    • 3.4.2: Inhaled
    • 3.4.3: Drug
  • 3.5: Global Allergy Diagnostics and Therapeutics Market by Test Type
    • 3.5.1: In vivo Test
    • 3.5.2: In vitro Test
  • 3.6: Global Allergy Diagnostics and Therapeutics Market by Drug Class
    • 3.6.1: Antihistamines
    • 3.6.2: Decongestants
    • 3.6.3: Corticosteroids
    • 3.6.4: Mast Cell Stabilizers
    • 3.6.5: Leukotriene Inhibitors
    • 3.6.6: Nasal Anti-cholinergic
    • 3.6.7: Immuno-modulators
    • 3.6.8: Epinephrine

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Allergy Diagnostics and Therapeutics Market by Region
  • 4.2: North American Allergy Diagnostics and Therapeutics Market
    • 4.2.2: North American Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.3: European Allergy Diagnostics and Therapeutics Market
    • 4.3.1: European Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.3.2: European Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.4: APAC Allergy Diagnostics and Therapeutics Market
    • 4.4.1: APAC Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.4.2: APAC Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.5: ROW Allergy Diagnostics and Therapeutics Market
    • 4.5.1: ROW Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.5.2: ROW Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Allergen Type
    • 6.1.3: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Test Type
    • 6.1.4: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Drug Class
    • 6.1.5: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Allergy Diagnostics and Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Allergy Diagnostics and Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Allergy Diagnostics and Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: R-Biopharm
  • 7.2: EUROIMMUN Medizinische Labordiagnostika
  • 7.3: DASIT
  • 7.4: AESKU
  • 7.5: BioMerieux
  • 7.6: Thermo Fisher Scientific
  • 7.7: Stallergenes Greer
  • 7.8: Minaris Medical America
  • 7.9: Siemens Healthcare
  • 7.10: Omega Diagnostics